MSB 2.51% 97.0¢ mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-182

  1. 3,825 Posts.
    lightbulb Created with Sketch. 359
    It's bullshit. people can talk about blind trials and other rubbish, the matter of the fact is the FDA is not keen on stem cells.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.